EW

Edwards Lifesci
NYSE

Real-time Quotes | Nasdaq Last Sale

103.80
-0.96
-0.92%
After Hours: 103.80 0 0.00% 17:48 06/24 EDT
OPEN
105.53
PREV CLOSE
104.76
HIGH
105.58
LOW
103.72
VOLUME
1.84M
TURNOVER
--
52 WEEK HIGH
105.58
52 WEEK LOW
66.45
MARKET CAP
64.53B
P/E (TTM)
77.62
1D
5D
1M
3M
1Y
5Y
Stocks That Hit 52-Week Highs On Thursday
    Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.
Benzinga · 6h ago
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23)
Benzinga · 9h ago
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22)
Benzinga · 1d ago
Top Stock Reports for Exxon Mobil, Texas Instruments & GlaxoSmithKline
Top Stock Reports for Exxon Mobil, Texas Instruments & GlaxoSmithKline
Zacks · 2d ago
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)
Benzinga · 2d ago
Stocks That Hit 52-Week Highs On Monday
    Monday's morning session saw 49 companies set new 52-week highs.
Benzinga · 3d ago
Transcatheter Devices Market Size, Share, Trends, Analysis and Forecast 2027
The Global is poised to value over USD 19.2 billion by 2027 end at a CAGR of over 12% during the forecast period 2020 to 2027.
Market Insight Reports · 3d ago
Transcatheter Devices Market Analysis and Forecast 2021: By Top Keyplayers Abbott, CryoLife, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, JenaValve Technology, Inc., Meril Lifesciences Pvt. Ltd., Neovasc Inc., and Terumo Corporation. | ARC
pune, India, Mon, 21 Jun 2021 00:00:08 / Comserve Inc. / -- The global transcatheter devices market size is expected to reach around US$ 19.4 Bn by 2026 and growing at a CAGR of around 12% over the forecast period 2019 to 2026.
Comserve · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EW. Analyze the recent business situations of Edwards Lifesci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 26 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EW stock price target is 100.00 with a high estimate of 114.00 and a low estimate of 71.00.
EPS
Institutional Holdings
Institutions: 1.44K
Institutional Holdings: 534.83M
% Owned: 86.04%
Shares Outstanding: 621.64M
TypeInstitutionsShares
Increased
422
24.18M
New
95
5.13M
Decreased
353
30.10M
Sold Out
104
3.31M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.09%
Healthcare Equipment & Supplies
+0.04%
Key Executives
Chairman/Director/Chief Executive Officer
Michael Mussallem
Chief Financial Officer/Vice President
Scott Ullem
Corporate Executive
Jean-Luc Lemercier
Vice President
Donald Bobo
Vice President
Daveen Chopra
Vice President
Catherine Szyman
Vice President
Huimin Wang
Vice President
Larry Wood
Lead Director/Independent Director
Martha Marsh
Independent Director
Kieran Gallahue
Independent Director
Leslie Heisz
Independent Director
Paul LaViolette
Independent Director
Steven Loranger
Independent Director
Ramona Sequeira
Independent Director
Nicholas Valeriani
Independent Director
Heisz Stone
No Data
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Webull offers kinds of Edwards Lifesciences Corp stock information, including NYSE:EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.